Status:
TERMINATED
A Study to Evaluate SU-VEID™ for Improving Peripheral Venous Access Success in Children
Lead Sponsor:
Mayo Clinic
Conditions:
Intravenous Access
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if use of the SU-VEID™ in children facilitates an increase success rate of peripheral intravenous starts, in comparison to the conventional method of vein ent...
Eligibility Criteria
Inclusion
- Patient age \< 18 years old.
- Pediatric patients in surgical pre-op (0-18 years old), requiring an I.V. catheter for surgery who are difficult venous access.
- Written informed consent/ assent from the patient or legal guardian.
Exclusion
- \- Patient age \> 18 years old.
Key Trial Info
Start Date :
March 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 21 2022
Estimated Enrollment :
169 Patients enrolled
Trial Details
Trial ID
NCT05204082
Start Date
March 28 2022
End Date
July 21 2022
Last Update
May 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905